Viovas Pharma Private Limited - Company Profile

It is a business services private limited company based in New Delhi, Delhi, India, established in 2023.
2023 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Viovas Pharma Private Limited

Viovas Pharma Private Limited, a active private limited company, was established on 14 July 2023 in New Delhi, Delhi, India. it holds CIN: U47721DL2023PTC417099. Registered under ROC Roc Delhi I. it is unlisted. It has an authorized capital of ₹4.99 M and a paid-up capital of ₹4.99 M.

Its leadership includes Ruby Chaudhary (Director), Vijay Pal Solanki (Director), Rajat Ranga (Director). Past directors included Ajay Kumar Singh. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Shop No 219 Plot No 2, Lsc Sec 19 Dwarka New Delhi, New Delhi, Delhi, 110075.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U47721DL2023PTC417099

  • Registration Number

    417099

  • Incorporation Date

    14 July 2023

  • Authorized Capital

    ₹4.99 M

  • Paid-Up Capital

    ₹4.99 M

  • ROC Code

    Roc Delhi I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 4.99 M
  • Paid Up Capital ₹ 4.99 M
  • Company Age 2 Year, 10 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Viovas Pharma Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Viovas Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Viovas Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Ruby Chaudhary Director 28 Apr 2025 Current
Vijay Pal Solanki Director 14 Jul 2023 Current
Rajat Ranga Director 28 Apr 2025 Current
Nasreen Shabbir Ahmed Director 28 Apr 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 28 Apr 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Viovas Pharma.

Enhance accessibility to Viovas Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Viovas Pharma revenue growth over time
Viovas Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Viovas Pharma?

Unlock access to Viovas Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Viovas Pharma?

Unlock and access historical data on people associated with Viovas Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Viovas Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Viovas Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Viovas Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Viovas Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Director Appointment

    The activity Ruby Chaudhary was appointed as a Director was appointed as a Director on 28 Apr 2025 & has been associated with this company since 1 year 1 month . was completed.

  • Director Appointment

    Rajat Ranga was appointed as a Director was appointed as a Director on 28 Apr 2025 & has been associated with this company since 1 year 1 month . was recorded as a recent event.

  • Director Appointment

    Nasreen Shabbir Ahmed was appointed as a Director was appointed as a Director on 28 Apr 2025 & has been associated with this company since 1 year 1 month . was recorded as a recent event.

  • Balance Sheet

    Progress on Viovas Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I. was documented.

  • Director Appointment

    Vijay Pal Solanki was appointed as a Director was appointed as a Director on 14 Jul 2023 & has been associated with this company since 2 years 10 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Viovas Pharma Private Limited?

The CIN of Viovas Pharma Private Limited is U47721DL2023PTC417099.

Where is Viovas Pharma Private Limited headquartered?

Viovas Pharma Private Limited is headquartered at Shop No 219 Plot No 2, Lsc Sec 19 Dwarka New Delhi, New Delhi, Delhi, 110075.

When was Viovas Pharma Private Limited incorporated?

Viovas Pharma Private Limited was incorporated on 14 July 2023.

Who are the current directors of Viovas Pharma Private Limited?

The current directors of Viovas Pharma Private Limited are

Is Viovas Pharma Private Limited a listed company?

Viovas Pharma Private Limited is unlisted.

What is the capital structure of Viovas Pharma Private Limited?

The authorized capital of Viovas Pharma Private Limited is ₹4.99 M, and the paid-up capital is ₹4.99 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available